Harry H. Mansbach - Nov 15, 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
Stock symbol
ETNB
Transactions as of
Nov 15, 2022
Transactions value $
-$30,476
Form type
4
Date filed
12/13/2022, 04:52 PM
Previous filing
Sep 30, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +9K +14.3% $0.00 72K Nov 15, 2022 Direct F1
transaction ETNB Common Stock Tax liability -$30.5K -3.11K -4.33% $9.79 68.8K Nov 15, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of department performance objectives.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.